loadpatents
name:-0.016349792480469
name:-0.01976203918457
name:-0.00062179565429688
BioArctic Neuroscience AB Patent Filings

BioArctic Neuroscience AB

Patent Applications and Registrations

Patent applications and USPTO patent grants for BioArctic Neuroscience AB.The latest application filed is for "method for treatment of traumatic brain injury targeting aggregated peptides".

Company Profile
0.23.18
  • BioArctic Neuroscience AB - Stockholm SE
  • Bioarctic Neuroscience AB -
  • BioArctic Neuroscience AB - Lagmansvagen 13 Lidingo WA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method for Treatment of Traumatic Brain Injury Targeting Aggregated Peptides
App 20180209994 - LANNFELT; Lars ;   et al.
2018-07-26
Spinal Cord Devices and Methods for Promoting Axonal Regeneration
App 20180140434 - Frostell; Arvid ;   et al.
2018-05-24
Spinal cord devices and methods for promoting axonal regeneration
Grant 9,895,234 - Frostell , et al. February 20, 2
2018-02-20
A.beta. protofibril binding antibodies
Grant 9,573,994 - Nerelius , et al. February 21, 2
2017-02-21
Antibodies and Vaccines for Use in Therapeutic and Diagnostic Methods for Alpha-Synuclein-Related Disorders
App 20160199522 - Lannfelt; Lars ;   et al.
2016-07-14
Antibodies and vaccines for use in therapeutic and diagnostic methods for .alpha.-synuclein-related disorders
Grant 9,315,569 - Lannfelt , et al. April 19, 2
2016-04-19
Abeta PROTOFIBRIL BINDING ANTIBODIES
App 20160009793 - NERELIUS; Charlotte ;   et al.
2016-01-14
Antibodies Specific For Soluble Amyloid Beta Peptide Protofibrils And Uses Thereof
App 20150307601 - GELLERFORS; Par ;   et al.
2015-10-29
Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other .alpha.-synucleinopathies
Grant 9,084,832 - Nordstrom , et al. July 21, 2
2015-07-21
Protofibril-Binding Antibodies And Their Use In Therapeutic And Diagnostic Methods For Parkinson's Disease, Dementia With Lewy Bodies And Other Alpha-Synucleinopathies
App 20150139900 - Nordstrom; Eva ;   et al.
2015-05-21
Protofibril selective antibodies and the use thereof
Grant 9,034,334 - Gellerfors , et al. May 19, 2
2015-05-19
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
Grant 8,999,936 - Gellerfors , et al. April 7, 2
2015-04-07
Spinal Cord Devices and Methods for Promoting Axonal Regeneration
App 20150088257 - Frostell; Arvid ;   et al.
2015-03-26
Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other .alpha.-synucleinopathies
Grant 8,968,734 - Nordstrom , et al. March 3, 2
2015-03-03
Protofibril-Binding Antibodies And Their Use In Therapeutic And Diagnostic Methods For Parkinson's Disease, Dementia With Lewy Bodies And Other Alpha-Synucleinopathies
App 20140363447 - Nordstrom; Eva ;   et al.
2014-12-11
Antibodies and Vaccines for Use in Therapeutic and Diagnostic Methods for Alpha-Synuclein-Related Disorders
App 20140335088 - Lannfelt; Lars ;   et al.
2014-11-13
Protofibril-binding antibodies and their use in thereapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies
Grant 8,859,501 - Nordstrom , et al. October 14, 2
2014-10-14
Antibodies and vaccines for use in therapeutic and diagnostic methods for .alpha.-synuclein-related disorders
Grant 8,809,506 - Lannfelt , et al. August 19, 2
2014-08-19
Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other .alpha.-synucleinopathies
Grant 8,632,776 - Nordstrom , et al. January 21, 2
2014-01-21
Protofibril-Binding Antibodies And Their Use In Therapeutic And Diagnostic Methods For Parkinson's Disease, Dementia With Lewy Bodies And Other Alpha-Synucleinopathies
App 20130309251 - Nordstrom; Eva ;   et al.
2013-11-21
Antibodies Specific For Soluble Amyloid Beta Peptide Protofibrils And Uses Thereof
App 20130236452 - Gellerfors; Par ;   et al.
2013-09-12
Antibodies specific for amyloid beta protofibril
Grant 8,409,575 - Lannfelt , et al. April 2, 2
2013-04-02
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
Grant 8,404,459 - Gellerfors , et al. March 26, 2
2013-03-26
Protofibril-Binding Antibodies and Their Use in Therapeutic and Diagnostic Methods for Parkinson's Disease, Dementia with Lewy Bodies and Other Alpha-Synucleinopathies
App 20120308572 - Nordstrom; Eva ;   et al.
2012-12-06
Antibodies Specific For Soluble Amyloid Beta Peptide Protofibrils And Uses Thereof
App 20120230912 - Gellerfors; Par ;   et al.
2012-09-13
Prevention And Treatment Of Alzheimer's Disease
App 20120156222 - LANNFELT; LARS
2012-06-21
Protofibril Selective Antibodies And The Use Thereof
App 20120076726 - GELLERFORS; Par ;   et al.
2012-03-29
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
Grant 8,106,164 - Gellerfors , et al. January 31, 2
2012-01-31
Protofibril selective antibodies and the use thereof
Grant 8,025,878 - Gellerfors , et al. September 27, 2
2011-09-27
Transgenic mouse expressing arctic mutation E693G
Grant 7,709,695 - Nilsson , et al. May 4, 2
2010-05-04
Arctic .beta. amyloid protofibril
Grant 7,700,719 - Lannfelt , et al. April 20, 2
2010-04-20
Protofibril Selective Antibodies And The Use Thereof
App 20090258009 - Gellerfors; Par ;   et al.
2009-10-15
Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein
App 20070099185 - Hagen; Frederick S. ;   et al.
2007-05-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed